⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CHRS News
Coherus Oncology, Inc. Common Stock
Form 8-K
sec.gov
CHRS
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
globenewswire.com
CHRS
Coherus to Participate in Upcoming Investor Conferences
globenewswire.com
CHRS
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
globenewswire.com
CHRS
Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026
globenewswire.com
CHRS
Homozygous Familial Hypercholesterolemia (HoFH) - 7MM Market, Epidemiology, and Forecast - 2036 | RNAi and Targeted Therapies Expand Uptake and Investment Opportunities
globenewswire.com
AMGN
CHRS
ARWR
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
globenewswire.com
CHRS
Colorado Ski Country USA Celebrates 30 Years of the Ski Passport as 2026-27 Pass Sales Open
globenewswire.com
CHRS
Coherus to Participate in Upcoming Investor Conferences
globenewswire.com
CHRS
Form 8-K
sec.gov
CHRS